Cytomegalovirus (CMV) vaccine


A very harmful infection for mother and child - Cytomegalovirus


Cytomegalovirus infection is common, with a prevalence in the adult population. Although initial (primary) CMV infections in children and adults are rarely symptomatic, transmitted in utero (in the mother's uterus) CMV infection can result in severe disability for life.

Most at risk are infants born to mothers who acquire CMV infection during pregnancy, which occurs in about 1/3 of these newborns. A congenital CMV infection can occur at any time during pregnancy.

Overall, 10-15% of infants born to women with CMV infection during pregnancy are symptomatic at birth, and among these symptomatic infants, 4-12% die in their first year of life and 70% 80% survive to suffer from permanent disabilities.

We are conducting a clinical study to assess the efficacy, safety and immunogenicity of an investigational vaccine against (CMV) in healthy women aged 18 to 40 years.

To participate, you must:

  • Be between 18 and 40 years old
  • Be in contact with children aged 5 and under for 8 hours per week

You will be reimbursed for expenses related to the study during your participation and you will be monitored by a medical team throughout the process.

I want to apply to this clinical study


For more information, contact us at
581 477-3439 (Québec), 819 346-2887 (Sherbrooke), 819 260-1172 (Victoriaville), 579 841-0571 (Joliette)
or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures


Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.


Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.


Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.


Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.


Step 5 | If you are eligible, you may then begin a clinical study with us.